TargetGene Biotechnologies is an innovative and agile biotechnology company in its development stage and poised for expansion.

The companys R&D is centered around creating efficient and extremely specific DNA editing solutions in living organisms.

Through its patented and patent-pending TGEE (genome editing engine) platform, TargetGene has developed RNA-guided gene targeting.

The company aims to implement the TGEE platform for human gene therapy with a focus on inherited diseases and cell-based immunotherapy.